Literature DB >> 19459869

Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration.

Fred K Chen1, Gurmit S Uppal, Robert E MacLaren, Peter J Coffey, Gary S Rubin, Adnan Tufail, G William Aylward, Lyndon Da Cruz.   

Abstract

BACKGROUND: To describe the 2- to 4-year visual and microperimetry outcomes of autologous retinal pigment epithelium (RPE)-choroid graft in patients with neovascular age-related macular degeneration (AMD).
METHODS: In this retrospective cohort study, 12 patients with subfoveal neovascular AMD who had undergone autologous RPE-choroid graft between August 2004 and June 2005 were reviewed. Change in visual acuity (VA), contrast sensitivity (CS), fixation stability and retinal sensitivity on microperimetry after 2-3 years and the rates of late postoperative complications were examined.
RESULTS: Patients were followed for 26-48 months (mean, 39). Median preoperative VA (logMAR) was 0.87 but declined to 1.43 (1 year), 1.46 (2 years) and 1.38 (3 years), P = 0.001. Median CS (logCS) was 0.75 preoperatively but declined to 0.45 at 2 years. Six patients had serial microperimetry. Fixation stability declined in 1 but improved in 2 patients. All 6 had decline in retinal sensitivity over the graft during follow up. Retinal detachment did not occur after 12 months but 8 developed epiretinal membrane, 12 had cystic retinal change over the graft and 4 developed recurrent choroidal neovascularization. However, 10 grafts retained autofluorescence signal at 18-48 months of follow up.
CONCLUSIONS: Autologous RPE-choroid graft can maintain VA, stable fixation and retinal sensitivity in some patients for over 3 years. The spatial correlation between graft autofluorescence, outer retinal structures on optical coherence tomography and retinal sensitivity are consistent with photoreceptor cell rescue. However, we caution the use of this technique as there is high complication rate and delayed loss of retinal function.

Entities:  

Mesh:

Year:  2009        PMID: 19459869     DOI: 10.1111/j.1442-9071.2009.01915.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  14 in total

1.  Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry.

Authors:  Annal D Meleth; Pradeep Mettu; Elvira Agrón; Emily Y Chew; Srinivas R Sadda; Frederick L Ferris; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

Review 2.  Cell replacement and visual restoration by retinal sheet transplants.

Authors:  Magdalene J Seiler; Robert B Aramant
Journal:  Prog Retin Eye Res       Date:  2012-07-05       Impact factor: 21.198

Review 3.  Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic.

Authors:  Paul Whiting; Julie Kerby; Peter Coffey; Lyndon da Cruz; Ruth McKernan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

4.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

5.  OCT angiography documented reperfusion of translocated autologous full thickness RPE-choroid graft for complicated neovascular age-related macular degeneration.

Authors:  M Veckeneer; C Augustinus; E Feron; P-P Schauwvlieghe; J Ruys; I Cosemans; J Van Meurs
Journal:  Eye (Lond)       Date:  2017-07-21       Impact factor: 3.775

6.  Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium.

Authors:  David E Buchholz; Britney O Pennington; Roxanne H Croze; Cassidy R Hinman; Peter J Coffey; Dennis O Clegg
Journal:  Stem Cells Transl Med       Date:  2013-04-18       Impact factor: 6.940

7.  Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE.

Authors:  Maria Kokkinaki; Niaz Sahibzada; Nady Golestaneh
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

8.  Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.

Authors:  Lyndon da Cruz; Kate Fynes; Odysseas Georgiadis; Julie Kerby; Yvonne H Luo; Ahmad Ahmado; Amanda Vernon; Julie T Daniels; Britta Nommiste; Shazeen M Hasan; Sakina B Gooljar; Amanda-Jayne F Carr; Anthony Vugler; Conor M Ramsden; Magda Bictash; Mike Fenster; Juliette Steer; Tricia Harbinson; Anna Wilbrey; Adnan Tufail; Gang Feng; Mark Whitlock; Anthony G Robson; Graham E Holder; Mandeep S Sagoo; Peter T Loudon; Paul Whiting; Peter J Coffey
Journal:  Nat Biotechnol       Date:  2018-03-19       Impact factor: 54.908

9.  Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab.

Authors:  P Alexander; F Mushtaq; C Osmond; W Amoaku
Journal:  Eye (Lond)       Date:  2012-02-10       Impact factor: 3.775

Review 10.  Stem cells in retinal regeneration: past, present and future.

Authors:  Conor M Ramsden; Michael B Powner; Amanda-Jayne F Carr; Matthew J K Smart; Lyndon da Cruz; Peter J Coffey
Journal:  Development       Date:  2013-06       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.